ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.89
0.44%
US Tech 100
21,531.20
0.02%
S&P 500
6,112.69
-0.03%
US Dollar vs CAD
1.41894
0.02%
Bitcoin
93,895.48
-1.96%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Trinity Biotech PLC (TRIB)

  7. Trinity Biotech PLC (TRIB) News

TRIB

Trinity Biotech (TRIB)

Trinity Biotech PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRIB
DateTimeSourceHeadlineSymbolCompany
02/14/20253:15PMEdgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
02/06/20258:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
02/06/20256:30AMGlobeNewswire Inc.Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal TrialNASDAQ:TRIBTrinity Biotech PLC
02/04/20257:36AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
01/29/20254:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
01/28/202510:33AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
01/28/20256:20AMGlobeNewswire Inc.Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) TechnologyNASDAQ:TRIBTrinity Biotech PLC
12/27/20243:14PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
12/27/20243:05PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRIBTrinity Biotech PLC
12/26/20245:19PMEdgar (US Regulatory)Form SCHEDULE 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:TRIBTrinity Biotech PLC
12/24/20247:33AMGlobeNewswire Inc.Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation PlanNASDAQ:TRIBTrinity Biotech PLC
12/19/20248:55PMEdgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
12/18/202411:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
12/18/202410:00AMGlobeNewswire Inc.Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIVNASDAQ:TRIBTrinity Biotech PLC
12/17/20243:56PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
12/17/20243:42PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRIBTrinity Biotech PLC
12/05/20243:30PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRIBTrinity Biotech PLC
12/02/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TRIBTrinity Biotech PLC
11/29/20243:45PMEdgar (US Regulatory)Form F-3/A - Registration statement by foreign private issuers: [Amend]NASDAQ:TRIBTrinity Biotech PLC
11/15/20244:00PMEdgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:TRIBTrinity Biotech PLC
11/15/202412:22PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
11/15/20248:00AMGlobeNewswire Inc.Trinity Biotech Announces Q3 2024 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
11/14/20244:26PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
11/07/202411:33AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
11/07/20247:19AMGlobeNewswire Inc.Trinity Biotech Regains Compliance with Nasdaq Listing RequirementsNASDAQ:TRIBTrinity Biotech PLC
10/25/202412:24PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
10/25/202412:23PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
10/25/20247:45AMGlobeNewswire Inc.Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing PlatformNASDAQ:TRIBTrinity Biotech PLC
10/25/20247:45AMGlobeNewswire Inc.Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCaptureNASDAQ:TRIBTrinity Biotech PLC
10/07/20249:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
 Showing the most relevant articles for your search:NASDAQ:TRIB

Your Recent History

ASX
ILA
Illawarra Series 2006 1 ...
NASDAQ
SNCY
Sun Country Airlines
USOTC
PMNXF
Perseus Mining (PK)
NYSE
MTN
Vail Resorts
NYSE
BPT
BP Prudhoe Bay Royalty
NYSE
VICI
Vici Properties
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads